Pelthos Therapeutics Inc. (NASDAQ:PTHS) filed a Form 8-K with the Securities and Exchange Commission on January 12, 2026, disclosing a material event. Pelthos Therapeutics Inc.'s…
Pelthos Therapeutics Inc. (NASDAQ:PTHS) filed a Form 8-K with the Securities and Exchange Commission on January 12, 2026, disclosing a material event.
Pelthos Therapeutics Inc.'s stock currently trades at $0.00 with a market capitalization of $0. The company's stock moved following the disclosure.
Current market data
NYSE · PTHS
$24.35
Down: -$0.01 · -0.04%
Live quote updated
Keep reading
sec_filing ·
analyst ·
sec_filing ·
earnings ·
